Interleukin 12 gene transfer into skin distant from the tumor site elicits antimetastatic effects equivalent to local gene transfer.
暂无分享,去创建一个
D. Mahvi | N. Yang | A. Rakhmilevich | P. Sondel | K. Oshikawa | F. Shi
[1] Ji-quan Chen,et al. Immunotherapy of spontaneous metastatic lung cancer with tumor antigen-pulsed, interleukin-12 gene-modified dendritic cells , 2003 .
[2] S. Morrison,et al. Antibody-cytokine fusion proteins: harnessing the combined power of cytokines and antibodies for cancer therapy. , 2002, Clinical immunology.
[3] S. Tominaga,et al. Expression of ST2 in helper T lymphocytes of malignant pleural effusions. , 2002, American journal of respiratory and critical care medicine.
[4] M Nakajima,et al. [Matrix metalloproteinase inhibitors]. , 2000, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.
[5] D. Mahvi,et al. Synergistic inhibition of tumor growth in a murine mammary adenocarcinoma model by combinational gene therapy using IL-12, pro-IL-18, and IL-1beta converting enzyme cDNA. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[6] H. Fujiwara,et al. Augmentation of local antitumor immunity in the liver by tumor vaccine modified to secrete murine interleukin 12 , 1999, Gene Therapy.
[7] Mamoru Ito,et al. Perforin‐dependent NK cell cytotoxicity is sufficient for anti‐metastatic effect of IL‐12 , 1999, European journal of immunology.
[8] K. Moelling,et al. Long-lasting anti-metastatic efficiency of interleukin 12-encoding plasmid DNA. , 1999, Human gene therapy.
[9] P. Musiani,et al. Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12. , 1999, Cancer research.
[10] F. Balkwill,et al. IL‐12 regulates VEGF and MMPs in a murine breast cancer model , 1998, International journal of cancer.
[11] J. Finke,et al. The CXC chemokines IP-10 and Mig are necessary for IL-12-mediated regression of the mouse RENCA tumor. , 1998, Journal of immunology.
[12] W. Alvord,et al. T cell- and NK cell-independent inhibition of hepatic metastases by systemic administration of an IL-12-expressing recombinant adenovirus. , 1998, Journal of immunology.
[13] Angray S. Kang,et al. Gene therapy with a single chain interleukin 12 fusion protein induces T cell-dependent protective immunity in a syngeneic model of murine neuroblastoma. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[14] D. Kufe,et al. Eradication of murine bladder carcinoma by intratumor injection of a bicistronic adenoviral vector carrying cDNAs for the IL-12 heterodimer and its inhibition by the IL-12 p40 subunit homodimer. , 1997, Journal of immunology.
[15] J. Norton,et al. IL-12 induces T helper 1-directed antitumor response. , 1997, Journal of immunology.
[16] M. Colombo,et al. Immunotherapy of experimental metastases by vaccination with interleukin gene-transduced adenocarcinoma cells sharing tumor-associated antigens. Comparison between IL-12 and IL-2 gene-transduced tumor cell vaccines. , 1996, Journal of immunology.
[17] M. Hitt,et al. Direct intratumoral injection of an adenovirus expressing interleukin-12 induces regression and long-lasting immunity that is associated with highly localized expression of interleukin-12. , 1996, Human gene therapy.
[18] Y. Kwong,et al. Adenovirus-mediated interleukin-12 gene therapy for metastatic colon carcinoma. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[19] A. Chang,et al. Injection of complementary DNA encoding interleukin-12 inhibits tumor establishment at a distant site in a murine renal carcinoma model. , 1996, Cancer research.
[20] N. Yang,et al. Gene gun-mediated skin transfection with interleukin 12 gene results in regression of established primary and metastatic murine tumors. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. Colombo,et al. Amount of interleukin 12 available at the tumor site is critical for tumor regression. , 1996, Cancer research.
[22] K. Takeda,et al. Liver NK1.1+ CD4+ alpha beta T cells activated by IL-12 as a major effector in inhibition of experimental tumor metastasis. , 1996, Journal of immunology.
[23] J. Norton,et al. High cytokine production and effective antitumor activity of a recombinant vaccinia virus encoding murine interleukin 12. , 1995, Cancer research.
[24] H. Fujiwara,et al. Administration of recombinant interleukin 12 prevents outgrowth of tumor cells metastasizing spontaneously to lung and lymph nodes. , 1995, Cancer research.
[25] L. Zitvogel,et al. Cancer immunotherapy of established tumors with IL-12. Effective delivery by genetically engineered fibroblasts. , 1995, Journal of immunology.
[26] E. Marshall. Cancer Trial of Interleukin-12 Halted , 1995 .
[27] R. D'Amato,et al. Inhibition of angiogenesis in vivo by interleukin 12. , 1995, Journal of the National Cancer Institute.
[28] L. Luistro,et al. Role of interferon-gamma in mediating the antitumor efficacy of interleukin-12. , 1995, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.
[29] G. Trinchieri,et al. CD4 T cells inhibit in vivo the CD8‐mediated immune response against murine colon carcinoma cells transduced with interleukin‐12 genes , 1995, European journal of immunology.
[30] R. Schreiber,et al. Recombinant IL-12 administration induces tumor regression in association with IFN-gamma production. , 1994, Journal of immunology.
[31] L. Luistro,et al. Antitumor and antimetastatic activity of interleukin 12 against murine tumors , 1993, The Journal of experimental medicine.
[32] J. Siegel,et al. Effects of IL-12 on the generation of cytotoxic activity in human CD8+ T lymphocytes. , 1993, Journal of immunology.
[33] M. Gately,et al. IL-12 induces the production of IFN-gamma by neonatal human CD4 T cells. , 1993, Journal of immunology.
[34] C. Hsieh,et al. Development of TH1 CD4+ T cells through IL-12 produced by Listeria-induced macrophages. , 1993, Science.
[35] G. Trinchieri,et al. Natural killer cell stimulatory factor (interleukin 12 [IL-12]) induces T helper type 1 (Th1)-specific immune responses and inhibits the development of IL-4-producing Th cells , 1993, The Journal of experimental medicine.
[36] G. Trinchieri,et al. Natural killer (NK) cell stimulatory factor or IL-12 has differential effects on the proliferation of TCR-alpha beta+, TCR-gamma delta+ T lymphocytes, and NK cells. , 1992, Journal of immunology.
[37] J. Ritz,et al. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF , 1992, The Journal of experimental medicine.
[38] I. Frank,et al. Natural killer (NK) cell stimulatory factor increases the cytotoxic activity of NK cells from both healthy donors and human immunodeficiency virus-infected patients , 1992, The Journal of experimental medicine.
[39] F. Podlaski,et al. Regulation of human lymphocyte proliferation by a heterodimeric cytokine, IL-12 (cytotoxic lymphocyte maturation factor). , 1991, Journal of immunology.
[40] G. Trinchieri,et al. Induction of interferon gamma production by natural killer cell stimulatory factor: characterization of the responder cells and synergy with other inducers , 1991, The Journal of experimental medicine.
[41] G. Trinchieri,et al. Identification and purification of natural killer cell stimulatory factor (NKSF), a cytokine with multiple biologic effects on human lymphocytes , 1989, Journal of Experimental Medicine.
[42] H. Wexler. Accurate identification of experimental pulmonary metastases. , 1966, Journal of the National Cancer Institute.
[43] D. Mahvi,et al. Granulocyte-macrophage colony-stimulating factor (GM-CSF) secreted by cDNA-transfected tumor cells induces a more potent antitumor response than exogenous GM-CSF , 1999, Cancer Gene Therapy.
[44] T. Warner,et al. Interleukin-12 Gene Transfer Results in CD8-Dependent Regression of Murine CT26 Liver Tumors , 1999, Annals of Surgical Oncology.
[45] Simon C Watkins,et al. Fibroblasts genetically engineered to secrete interleukin 12 can suppress tumor growth and induce antitumor immunity to a murine melanoma in vivo. , 1994, Cancer research.